Application Information

This drug has been submitted to the FDA under the reference 207947/001.

Names and composition

"UPTRAVI" is the commercial name of a drug composed of SELEXIPAG.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
207947/001 UPTRAVI SELEXIPAG TABLET/ORAL 0.2MG
207947/002 UPTRAVI SELEXIPAG TABLET/ORAL 0.4MG
207947/003 UPTRAVI SELEXIPAG TABLET/ORAL 0.6MG
207947/004 UPTRAVI SELEXIPAG TABLET/ORAL 0.8MG
207947/005 UPTRAVI SELEXIPAG TABLET/ORAL 1MG
207947/006 UPTRAVI SELEXIPAG TABLET/ORAL 1.2MG
207947/007 UPTRAVI SELEXIPAG TABLET/ORAL 1.4MG
207947/008 UPTRAVI SELEXIPAG TABLET/ORAL 1.6MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
207947/001 UPTRAVI SELEXIPAG TABLET/ORAL 0.2MG
207947/002 UPTRAVI SELEXIPAG TABLET/ORAL 0.4MG
207947/003 UPTRAVI SELEXIPAG TABLET/ORAL 0.6MG
207947/004 UPTRAVI SELEXIPAG TABLET/ORAL 0.8MG
207947/005 UPTRAVI SELEXIPAG TABLET/ORAL 1MG
207947/006 UPTRAVI SELEXIPAG TABLET/ORAL 1.2MG
207947/007 UPTRAVI SELEXIPAG TABLET/ORAL 1.4MG
207947/008 UPTRAVI SELEXIPAG TABLET/ORAL 1.6MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved